[Frontiers in Bioscience E3, 233-239, January 1, 2011]

Development of placenta in a rodent - model for human placentation

Alan Serman1, Ljiljana Serman2

1Clinic of Obstetrics and Gynecology, Clinical Hospital, Sveti Duh, Zagreb, Croatia, 2Department of Biology, School of Medicine, University of Zagreb, Zagreb, Croatia

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. Genes involved in the placenta development
4. Features of the rodent placenta
5. Concluding remarks and perspectives
6. Acknowledgements
7. References

1. ABSTRACT

Rodents provide an excellent experimental model to study human placental development. In this review, our aim was to explain major events that underlie the placental development in mammals in general, and specifically in rodent. Those events include trophoblast cell proliferation, decidual reaction and contact between the mesenchyme of the allantois with ectoplacental cone, all orchestrated by activation of a series of genes. We also aimed to compare molecular and genetic events of rodent and human placentation. Employing the rodent placenta development model will yield better understanding of these processes in other mammals, especially in humans.

2. INTRODUCTION

The purpose of this paper is to give an overview of rodent placenta development as model for normal human embryonic development. After fertilization, the zygote starts the process of cleavage, consisting of a number of mitotic divisions, giving rise to the blastocyst. In the blastocyst, the separation into embryoblast and trophoblast tissues represents the first differentiation and appears very early in development (1). The prospective trophoblast becomes polarized in the outer layer of the embryo as early as at 16-cell stage, when genes responsible for its differentiation start to be expressed (2). The marker of the future trophoblast cells is Cdx-2 gene (caudal type homeobox 2) (3); and its expression in the embryonal stem cells is sufficient for their differentiation into trophoblast (4,5), whereas Cdx-2 knockouts, although capable of initiating cell cleavage, cannot support the development of the trophoblast to completion (6,7). Its protein product is homeodomainic transcriptional factor which acts as repressor for Oct4 (Octamer 4; POU class 5 homeobox 1) and Nanog2 (Nanog homeobox) genes, markers of embryoblast and embryonal stem cells that are indispensable for their differentiation (8). In embryoblast cells, Oct4 is hypomethylated and acetylated, whereas in the trophoblast cells is hypermethylated and deacetylated and inhibits its differentiation (9).

The blastocyst has to implant to form placenta and thus enable successful progress of pregnancy. The relative importance of throphoblast cells for implantation is apparent from the fact that, e.g. in the mouse preimplantation embryo, composed of 64 blastomeres, only 13 cells represent the future cells of the embryoblast, whereas all the other cells future trophoblast (10). Unlike humans, where implantation and placentation occured on the same side, in rodents, the implantation takes place at the antimesomethral wall of the uterus during the fifth day of embryonic development, and the final placenta is formed on the mesomethral wall of uterus (11). Placenta is of chorioallantoic type because the blood vessels which supply chorion originate from the mesenchyme of the allantois (12). In rats, before formation of the chorioallantoic placenta takes place, the placental functions are performed by the yolk sac, which represents the only place for metabolic exchanges and the main nutritive organ until the 11th day of gestation. After that period the yolk sac functions jointly with the chorioallantoic placenta (13). In humans, these features are similar but not so pronounced while still retaining its haematopoetic task (14).

3. GENES INVOLVED IN THE PLACENTA DEVELOPMENT

The ectoplacenta emerges on the eighth day of gestation from the trophoblast cells which form the ectoplacental cone, and during the ninth day maternal lacunas without the endothelium arise within this ectoplacenta (Figure 1) (15,16). At the beginning of the 11th day of gestation, the mesenchyme of the allantois establishes the contact with the ectoplacenta, and due to its ability of angiogenesis, it differentiates into fetal mesenchyme and bloodvessel channels supplied with endothelium (17). This mesenchyme penetrates deeply into ectoplacental trophoblast, among the already formed maternal lacunas, thus creating labyrinth, i.e. the region where maternal and fetal blood circulation coexist and where the exchange of metabolites takes place (18). This is a very sensitive period during development of placenta, when the coordination between trophoblast and maternal lacunas is crucial for development of the labyrinth. There is no successful continuation of gestation without a well developed labyrinth. Therefore, it is not surprising to find a large number of the already known genes to be involved in this process. Myriam Hemberger and James C. Cross have classified these genes into four groups, responsible for particular phase of placental development: 1) genes responsible for differentiation of the trophoblast giant cells, (TGC), 2) genes important for chorioallantoic fusion, 3) genes responsible for the initiation of villous branching and vascularisation of trophoblast, and 4) genes for the transport of matter through the labyrinth (19). We will briefly summarize each of these groups as to have a more detailed view into events taking place in each one of the aforementioned phases.

Differentiation of the trophoblast giant cells (considered here are the secondary giant cells only, not the primary ones, which surround the embryo at the very beginning of gestation, immediately upon the implantation) that are responsible for the endovascular invasion of the trophoblast into the endothelium of maternal spiral arteries, is determined by the interaction of two genes. The first is Mash 2, which stimulates throphoblast proliferation and prevents its differentiation and is, thus, responsible for the maintenance of its cells (20). In contrast, Hand 1 stimulates the diferentiation of trophoblast cells into giant cells; thus by blocking its expression in the mouse. Riely has obtained mutant animals that can reach, at most, the seventh and a half day of embryonic development (21,22). The Hand1 null mice do not form trophoblast giant cells (TGC) and display an exceedingly small ectoplacental cone (23,24). Products of both of these genes are basic �helix-loop-helix� proteins (acting as transcription factors), which are localized in the ectoplacental cone and in the basal layer (spongiotrophobast). These areas represent the layers of future placenta which contain the precursors of trophoblast giant cells indicating that the antagonistic activities of Mash2 and Hand1 have to be coordinated (25,26).

To make the further discussion on genes required for successful placentation more comprehensible it is necessary to remind that placenta is composed of three completely different tissue types: epithelial cells derived from the trophoblast, and stromal and blood vessel cells derived from the extraembryonic mesoderm (in rodents they are derived from the mesoderm of allantois). Thus, one could say that placenta is the product of fusion of two extraembryonic structures, chorion and allantois (27).

For this fusion to take place, two proteins seem important: the vascular cell adhesion molecule 1 (VCAM-1) (the transmembrane glycoprotein, a member of the group of adhesive molecules of the immunoglobulin gene superfamily) present on the surface of allantois, and its ligand, alpha4 integrin, present on the basal surface of chorion (28). Cells that lack functional expression of both of these genes, develop seemingly normal allantois and chorion, but are unable to establish stable contact between these two types of tissues (29).

Once the chorio-allantoic fusion is succesfully established, the next phase in development of placenta takes place, which is characterized by initiation of villous branching and vascularization of trophoblast. The main actor during initiation of villous branching is the mammalian homologue of the Gcm1 (glial cell missing 1) gene, originally discovered in Drosophila (30). Studies of its distribution in mammals have shown that Gcm1 is highly expressed specifically in placenta (31). In the phase immediately prior to chorio-allantoic fusion, Gcm1 mRNA was detected in rare trophoblast cells of chorion (32). Its protein product, however, starts to be synthetized only following the chorio-allantoic fusion by a mechanism of adhesion-dependent signaling from cell membrane to translation control site in the cytoplasm. This type of post-transcriptional control is found in embryonal development of other organs, as well as in tumorigenesis (33).

Whereas the Gcm1 gene serves at the initiation stage of villous branching, for the continuation of branching and vascularization of the trophoblast a large number of genes seems to be responsible. Of those, two seem to be important for the growth of labyrinth (the main part of rodent placenta), based on its defective development when gene is mutated: Gab 1 (signal adaptor molecule for a range of proteins like the Fibroblast growth factor receptor - Fgfr2, Epidermal growth factor receptor - Egfr, receptor for leukemia inhibitory factor (LIF)) and Sos 1 (guanine exchanger or GDP/GTP exchanger) (19).

Finally, it remains for us to consider those genes responsible for transplacental transport of various substances and molecules. Among molecules that appear critical for such a function are connexins Cx26 and Cx31 (34). Connexins Cx26 function as bridges linking neighboring cells and they have been identified as channels for transport of glucose across hemochorial barrier (35). Connexin Cx31 plays the role in the differentiation of the trophoblast cells (36).

Our experiments using DNA demethylation agent 5-azacytidine (5azaC), which disrupts normal gene expression, point to the importance of orderly gene expression during placental development in rats. Treatment of rats with 5azaC at different time points during gestation produces changes in morphology of the placenta. We observed reduced or entirely absent labyrinth, placental mass and proliferation capacity of throphoblast cells (37). In addition, we have found significant changes in glycosylation of cytosolic and membranous proteins (37,38). DNA methylation is unquestionably important for the process of placentation and in humans as indicated by many research (39). Novakovic and collaborators discover data which strongly implicates epigenetic regulation of the DNA methyltransferase gene family in the establishment of the unique epigenetic profile of extraembryonic tissue in humans (40). Examination of invasive choriocarcionoma cell lines revealed altered methylation patterns consistent with a role of methylation change in gestational trophoblastic disease. The distinct pattern of tumour-associated methylation implicates a coordinated series of epigenetic silencing events, similar to those associated with some tumours, in the distinct features of normal human placental invasion and function (41).

4. FEATURES OF THE RODENT PLACENTA

Similar to humans, rodent placenta is of hemochorial type, i.e., the trophoblast cells originating from chorion are in direct contact with the erythrocytes, of the maternal blood (42,43). In hemochorial placenta, trophoblast invasion takes place in the uterine endometrium (44). Responsible for this invasion are two types of cells: the trophoblast giant cells (TGC) (Figure 2) and the glycogen-rich trophoblast cells (45) (Figure 2 E, F, G, H; analyzed in our laboratory on Fisher rat). The glycogen-rich trophoblast cells form structure analogous to the extravillous invasive interstitial trophoblast in humans, and are thus responsible for the interstitial invasion of uterine endometrium (46). Trophoblast giant cells of the rat are analagous to the endovascular trophoblast in humans and as such enable invasion into the maternal blood circulation system (47). These processes are associated with redistribution of cell-cell and cell-substrate adhesion molecules, cross talk between external extracellular matrix through adhesion molecules and the expression of several proteolytic enzymes, including matrix metalloproteases and serine proteases (48,49). Defects in these processes may lead to diseases such as gestational preeclampsiae. Preeclampsia is a hypertensive disorder unique to human pregnancy that can result in significant morbidity and mortality for mother and fetus (50). One possible mediator may be the matrix metalloproteases, a family of proteinases typically recognized for long term tissue remodelling (51).

The result of trophoblast invasion is the creation of functional placenta with three essential parts: the basal zone, the labyrinth and decidua (52). Decidua grows at smaller rate as gestation progresses since the labyrinth reaches its maximum size in the third part of gestation (53) (Figure 2; shown on Fisher rat analyzed in our laboratory). The basal zone of the placenta consists of trophoblast stem cells and three types of differentiated cells: trophoblast giant cells, spongyotrophoblast cells and glycogen-rich cells (54). This second generation of giant cells (secondary giant cells) emerges in the border between the basal zone and the decidual part of placenta (55). Here there are no fetal blood vessels nor the chorioallantoic mesenchyme, only the blood circulation system which exclusively belongs to the mother (56).

The labyrinth zone is located on the fetal side of placenta and represents the space where one can find both maternal lacunes and fetal blood vessels (57) (Figure 2B, 2C; Fisher rat). The labyrinth is constructed of cytotrophoblast stem cells which differentiate at all times into trophoblast giant cells (TGC) or agglomerate into syncytium (58) (Figure 2E, 2F, 2H; Fisher rat). Many genes involved in TGC development and function are conserved between rodents and humans, such as transcription factors, proteases and cell adhesion molecules (59).

System of fetal capillaries and maternal lacunas form two separate blood circulations separated by the placental membrane (60). In rats, this membrane is composed of three layers: the outer layer of trophoblast bathed directly by maternal blood and inner two layers which are multinucleated and syncytial in nature (61). For this reason the rat placenta belongs to the group of hemotrichorionic placentas, as opposed to human placenta which is monochoryal (62). In monochoryal placentas, the villi have a nearly complete cytotrophoblast layer underlying the surface layer of syncytial trophoblast during most of the first trimester. As gestation proceeds the cytotrophoblast layer becomes discontinuous and the cytotrophoblast cells become more stellate, at which time the placenta is considered to be villous hemomonochorial (63). Syncytiotrophoblast's function is to produce proteins and steroid hormones (64).

In rat hemotrichorionic placenta, the outer layer, throphoblast, later develops into trophoblast giant cells. These cells (TGC) show reduced levels of p53 and Rb protein synthesis which are indispensable for their exit from the cell cycle and entry into the endocycle of genomic amplification, and synchronous rise in synthesis of cyclin E, which is indispensable for the transition into the S-phase (65,66). Towards the end of pregnancy the TGC-layer loses its regular shape and thins down on some places to sheer bilayer of cell membranes (67). Similar thinning of the hemochorial barrier happens generally in all placentas in order to increase transport efficiency for better growth of the fetus (68).

This fact is especially interesting in light of the toxicological studies on the placenta. Reproductive and developmental toxicology studies have yielded evidence that metals from tobacco smoke can act as endocrine-disrupting chemicals in reproductive tissues (69). The results were initially obtained in rat placenta, and then confirmed at the human (70,71).

Because of all these characteristic, i.e. haemochorial and chorioallantois placentation as well as the depth of trophoblast invasion (especially rats) and a number so far discovered genes in human and rodent (especially mouse) performing similar functions, we can generally consider the rodent placenta as a suitable model for studying not only human placentation, but also diseases that are associated with it.

5. CONCLUDING REMARKS AND PERSPECTIVES

Thanks to the progress in medicine and to the fact that placenta is increasingly becoming an interesting organ to study, primarily in its obstetric sense and function, but also in its evolutionary, immunological, and genetic sense, there appears a necessity for the animal experimental model whose placental development resembles closely to that of humans. We suggest that the development of placenta in a rodent is such a model, uniquely helpful to investigate trophoblast cell invasion as well as the impacts of various teratogenic agents on development of placenta, as the exclusive reproductive organ in mammals.

6. ACKNOWLEDGMENTS

We thank Zoran Ilic for critical reading of the manuscript. The authors declare that there are no conflicts of interest

7. REFERENCES

1. H. Sasaki: Mechanisms of trophectoderm fate specification in preimplantation mouse development. Dev Growth Differ 52, 263-273 (2010)
doi:10.1111/j.1440-169X.2009.01158.x

2. N. Dard, S. Louvet-Vallée and B. Maro: Orientation of mitotic spindles during the 8- to 16-cell stage transition in mouse embryos.PLoS One 4, 8171 (2009)
doi:10.1371/journal.pone.0008171
PMid:19997595    PMCid:2781390

3. A. Meissner and R. Jaenisch: Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439, 212-215 (2006)
doi:10.1038/nature04257
PMid:16227971

4. A. Ralston and J. Rossant: Genetic regulation of stem cell origins in the mouse embryo. Clin Genet 68,106-112 (2005)
doi:10.1111/j.1399-0004.2005.00478.x
PMid:15996204

5. E. Tolkunova, F. Cavaleri, S. Eckardt, R. Reinbold, L. K. Christenson, H. R. Scholer and A. Tomilin The caudal-related protein cdx2 promotes trophoblast differentiation of mouse embryonic stem cells. Stem Cells 24, 139-144 (2006)
doi:10.1634/stemcells.2005-0240
PMid:16210407

6. H. Sritanaudomchai, M. Sparman, M. Tachibana, L. Clepper, J. Woodward, S. Gokhale, D. Wolf, J. Hennebold, W. Hurlbut, M. Grompe and S. Mitalipov: CDX2 in the formation of the trophectoderm lineage in primate embryos. Dev Biol 335, 179-187 (2009)
doi:10.1016/j.ydbio.2009.08.025
PMid:19733166

7. A. Ralston and J. Rossant: Cdx2 acts downstream of cell polarization to cell-autonomously promote trophectoderm fate in the early mouse embryo. Dev Biol 313, 614-629 (2008)
doi:10.1016/j.ydbio.2007.10.054
PMid:18067887

8. H. Niwa, Y. Toyooka, D. Shimosato, D. Strumpf, K. Takahashi, R. Yagi and J. Rossant: Interaction between Oct3/4 and Cdx2 determines trophoectoderm differentiation. Cell 123, 917-929 (2005)
PMid:16456133

9. S. R. Hough, I. Clements, P. J. Welch and K. A. Wiederholt: Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanong. Stem Cells 24, 1467-1475 (2006)
doi:10.1634/stemcells.2005-0475
PMid:1759686

10. S. F. Gilbert, Developmental biology. Sunderland MA: Sinauer Associates, Inc., Publishers (2002)

11. A. O. Welsh and A. C. Enders: Chorioallantoic placenta formation in the rat: I. Luminal epithelial cell death and extracellular matrix modifications in the mesometrial region of implantation chambers. Am J Anat 192, 215-231 (1991)
doi:10.1002/aja.1001920302
PMid:19007985

12. L. K. Proctor, C. Dunk, D. Baczyk, J. C. Kingdom and S. L. Adamson: Early gene expression and morphogenesis of the murine chorioallantoic placenta in vivo and in vitro. Placenta 30, 96-104 (2009)
doi:10.1016/j.placenta.2008.09.014
PMid:3578838

13. A. O. Welsh and A. C. Enders: Trophoblast-decidual cell interactions and establishment of maternal blood circulation in the parietal yolk sac placenta of the rat. Anat Rec 217, 203-219 (1987)
doi:10.1002/ar.1092170213
PMid:20169616

14. J. Pereda, J. I. Monge and G. Niimi : Two different pathways for the transport of primitive and definitive blood cells from the yolk sac to the embryo in humans. Microsc Res Tech. (Epub ahead of print) (2010)
doi:10.1002/jemt.20823

15. E. P. C. T. DeRijk, E. van Esch and G. Flik: Pregnancy dating in the rat: placental morphology and maternal blood parameters. Toxicol Pathol 30, 271-282 (2002)
doi:10.1080/019262302753559614
PMid:18886024

16. J. Bridgman: A morphological study of the development of the placenta of the rat. An histological and cytological study of the development of the chorioallantoic placenta of the white rat. J Morph 83, 195-222 (1948)
doi:10.1002/jmor.1050830204
PMid:15272021

17. M. Errico, T. Riccioni, S. Iyer, C. Pisano, K. R. Acharya, M. G. Persico and S. De Falco: Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor. J Biol Chem. 279, 43929-4339 (2004)
doi:10.1074/jbc.M401418200

18. J. Davies and S. R. Glaser: Histological and fine structural observations on the placenta of the rat. Acta Anat 69, 542-608 (1968)
doi:10.1159/000143100

19. M. Hemberger and J. C. Cross: Genes governing placental development. Trends Endocrinol Metab 12,162-168 (2001)
doi:10.1016/S1043-2760(01)00375-7
PMid:15901283

20. A. H. El-Hashash, P. Esbrit and S. J. Kimber: PTHrP promotes murine secondary trophoblast giant cell differentiation through induction of endocycle, upregulation of giant-cell-promoting transcription factors and suppression of other trophoblast cell types. Differentiation 73, 154-174. (2005)
doi:10.1111/j.1432-0436.2005.00013.x
PMid:18196965

21. D. M. Martindill and P.R.Riley: Cell cycle switch to endocycle: the nucleolus lends a hand. Cell Cycle 7, 17-23 (2008)
doi:10.4161/cc.7.1.5228
PMid:9500551

22. P. Riley, L. Anson-Cartwright and J. C. Cross.: The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18, 271-275 (1998)
doi:10.1038/ng0398-271
PMid:10753973

23. M. T. Scott and N. Morrice, K. L. Ball: Reversible phosphorylation at the C-terminal regulatory domain of p21 (Waf1/Cip1) modulates proliferating cell nuclear antigen binding. J Biol Chem 275, 11529-11537 (2000)
doi:10.1074/jbc.275.15.11529
PMid:16503349

24. A. C. Ferguson-Smith, T. Moore, J. Detmar, A. Lewis, M. Hemberger, H. Jammes, G. Kelsey, C. T. Roberts, H. Jones and M. Constancia: Epigenetics and imprinting of the trophoblast - A workshop report. Placenta 27 Suppl A, S122-126 (2006)

25. D. R. Arnold, R. Lefebvre and L.C. Smith: Characterization of the placenta specific bovine mammalian achaete scute-like homologue 2 (Mash2) gene. Placenta 27, 1124-1131 (2006)
doi:10.1016/j.placenta.2005.12.001
PMid:15196947

26. M. Hughes, N. Dobric, I. C. Scott, L. Su, M. Starovic, B. St-Pierre, S. E. Egan, J. C. P. Kingdom and J. C. Cross: The Hand1, Stra13 and Gcm1 transcription factors override FGF signaling to promote terminal differentiation of trophoblast stem cells. Dev Biolog 271, 26-37 (2004)
doi:10.1016/j.ydbio.2004.03.029
PMid:7768182

27. K. M. Downs and R. L. Gardner: An investigation into early placental ontogeny: allantoic attachment to chorion is selective and developmentally regulated. Development 121, 407-416 (1995)

28. G. C. Gurtner, V. Davis, H. Li, M. J. McCoy, A. Sharpe and M. I. Cybulsky: Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 9, 1-14 (1995)
doi:10.1101/gad.9.1.1
PMid:12814941

29. J. C. Cross, D.G. Simmons and E. D. Watson: Chorioallantoic morphogenesis and formation of the placental villous tree. Ann N Y Acad Sci 995, 84-93 (2003)
doi:10.1111/j.1749-6632.2003.tb03212.x

30. B. Stecca, B. Nait-Oumesmar, K. A. Kelley, A. K. Voss, T. Tomas and R. A. Lazzarini: Gcm1 expression defines three stages of chorio-allantoic interaction during placental development. Mech Dev 115, 27-34 (2002)
doi:10.1016/S0925-4773(02)00095-3
PMid:19219068

31. D. Baczyk, S. Drewlo, L. Proctor, C. Dunk, S. Lye and J. Kingdom: Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast.Cell Death Differ 16, 719-727 (2009)
doi:10.1038/cdd.2009.1
PMid:10888880

32. L. Anson-Cartwright, K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini and J. C. Cross: The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet 25, 311-314 (2000)
doi:10.1038/77076
PMid:17637831    PMCid:1910610

33. S. J. Sequeira, A. C. Ranganathan, A. P. Adam, B. V. Iglesias, E. F. Farias and J. A. Aguirre-Ghiso: Inhibition of proliferation by PERK regulates mammary acinar morphogenesis and tumor formation. PLoS ONE 2, e615. (2007)
doi:10.1371/journal.pone.0000615
PMid:16271349

34. A. Malassiné and L. Cronier: Involvement of gap junctions in placental functions and development. Biochim Biophys Acta 1719, 117-124 (2005)
doi:10.1016/j.bbamem.2005.09.019
PMid:16310041

35. C. D. Pfarrer, C. Heeb and R. Leiser: Expression of gap junctional connexins 26, 32 and 43 in bovine placentomes during pregnancy. Placenta 27, 79-86 (2006)
doi:10.1016/j.placenta.2004.11.011
PMid:18783825

36. M. Kibschull, A. Gellhaus and E. Winterhager: Analogous and unique functions of connexins in mouse and human placental development. Placenta 29, 848-854. (2008)
doi:10.1016/j.placenta.2008.07.013
PMid:17509679

37. L. Serman, M. Vlahovic, M. Sijan, F. Bulic-Jakus, A. Serman, N. Sincic, R. Matijevic, G. Juric-Lekic and A. Katusic: The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta 28, 803-811 (2007)
doi:10.1016/j.placenta.2007.04.001

38. L. Serman, M. Sijan, R. Kuzmic, N. Sincic, A. Serman, F. Bulic-Jakus, M. Vlahovic, G. Juric-Lekic and A. Katusic: Expressionsveranderungen von membranproteinen in mit 5-azacytidin behandelten rattenplazentas. Tierarztliche Umschau 63, 391-395 (2008)
PMid:17243571

39. A. Serman, M. Vlahovic, L. Serman and F. Bulic-Jakus: DNA methylation as a regulatroy mechanism for gene expression in mammals. Coll Antropol 30, 921-929 (2006)
PMid:20071334    PMCid:2843208

40. B. Novakovic, N. C. Wong, M. Sibson, H. K. Ng, R. Morley, U. Manuelpillai, T. Down, V. K. Rakyan, S. Beck, S. Hiendleder, C. T. Roberts, J. M. Craig and R. Saffery: DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta. J Biol Chem 285, 9583-9593 (2010)
doi:10.1074/jbc.M109.064956
PMid:18708652

41. B. Novakovic, V. Rakyan, H. K. Ng, U. Manuelpillai, C. Dewi, N. C. Wong, R. Morley, T. Down, S. Beck, J. M. Craig and R. Saffery Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 14, 547-554 (2008)
doi:10.1093/molehr/gan046
PMid:19800685

42. A. M. Carter: Evolution of factors affecting placental oxygen transfer. Placenta. Suppl A, S19-25 (2009)

43. M. G. Elliot and B. J. Crespi: Phylogenetic evidence for early hemochorial placentation in eutheria. Placenta 30, 949-967 (2009)
doi:10.1016/j.placenta.2009.08.004
PMid:19344949    PMCid:2674526

44. G. X. Rosario, R. Ain, T. Konno and M. J. Soares: Intrauterine fate of invasive trophoblast cells. Placenta 30, 457-463 (2009)
doi:10.1016/j.placenta.2009.02.008
PMid:12561726

45. A. C. Enders and A. M. Carter: What can comparative studies of placental structure tell us? Placenta 25: Suppl A, S3-S9 (2004)

46. T. G. Zybina, P. Kaufmann, H. G. Frank, J. Freed, M. Kadyrov and S. Biesterfeld: Genome multiplication of extravillous trophoblast cells in human placenta in the course of differentiation and invasion into endometrium and myometrium. I. Dynamics of polyploidization. Tsitologiia 44, 1058-1067 (2002)

47. E. V. Zybina, T. G. Zybina and G. I. Stein: Trophoblast cell invasiveness and capability for the cell and genome reproduction in rat placenta. Early pregnancy 4, 29-57(2000)
PMid:17981716

48. G. Ghersi: Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis. Front Biosci 13, 2335-2355 (2008)
doi:10.2741/2848
PMid:14613514    PMCid:270068

49. N. Pecina-Slaus:Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int. 3,17 (2003)
doi:10.1186/1475-2867-3-17
PMid:17127254

50. R. Rampersad and M. D. Nelson: Trophoblast biology, responses to hypoxia and placental dysfunction in preeclampsia. Front Biosci 12, 2447-2456 (2007)
doi:10.2741/2246
PMid:17127257

51. M. M. Lalu and X. Han: Matrix metalloproteinases: control of vascular function and their potential role in preeclampsia. Front Biosci 12, 2484-2493 (2007)
doi:10.2741/2249
PMid:16542720

52. B. Huppertz, G. Burton, J. C. Cross and J. C. P. Kingdom: Placental morphology: From molecule to mother - A dedication to Peter Kaufmann - A rewiew. Placenta 27, S3-S8 (2006)
doi:10.1016/j.placenta.2006.01.007
PMid:14973263

53. P. M. Coan, A. C. Fergudson Smith and G. J. Burton: Developmental dynamics of the definitive mouse placenta assessed by stereology. Bio Reprod 70, 1806-1813 (2004)
doi:10.1095/biolreprod.103.024166
PMid:19716815

54. D. R. Natale, M. Hemberger, M. Hughes and J. C. Cross: Activin promotes differentiation of cultured mouse trophoblast stem cells towards a labyrinth cell fate. Dev Biol 335, 120-131 (2009)
doi:10.1016/j.ydbio.2009.08.022
PMid:17627829

55. E. V. Zybina and T. G. Zybina: Modifications of nuclear envelope during differentiation and depolyploidization of rat trophoblast cells. Micron 39, 593-606 (2007)
doi:10.1016/j.micron.2007.05.006
PMid:12596737

56. J. C. Cross, D. Baczyk, N. M. Dobric, M. Hemberger, M. Hughes, D. G. Simmons, H. Yamamoto and J. C. Kingdom: Genes, development and evolution of the placenta. Placenta 24, 123-30 (2003)
doi:10.1053/plac.2002.0887
PMid:16338456

57. R. Pijnenborg and L. Vercruysse: Mathias Duval on placental development in mice and rats. Placenta 27, 109-118 (2006)
doi:10.1016/j.placenta.2005.01.009

58. R. Ain, L. N. Canham and M. J. Soares: Gestation stage-dependent intrauterine trophoblast cell invasion in the rat and mouse: novel endocrine phenotype and regulation. Dev Biol 260, 176-190 (2003)
doi:10.1016/S0012-1606(03)00210-0
PMid:19876834

59. D. Hu and J. C. Cross: Development and function of trophoblast giant cells in the rodent placenta. Int J Dev Biol 54, 341-354 (2010)
doi:10.1387/ijdb.082768dh
PMid:15662707

60. E. W. Carney, A. R. Scialli, R. E. Watson and J. M. De Sesso : Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Birth Defects Res C Embryo Today 72, 345-360 (2004)
doi:10.1002/bdrc.20027

61. A. Mess and A. M. Carter: Evolution of the placenta during the early radiation of placental mammals. Comp Biochem Physiol A Mol Integr Physiol 148, 769-779 (2007)
doi:10.1016/j.cbpa.2007.01.029
PMid:19876821

62. A. M. Carter and A. C. Enders : Placentation in mammals once grouped as insectivores. Int J Dev Biol 54, 483-493 (2010)
doi:10.1387/ijdb.082830ac
PMid:17980906

63. A. M. Carter: Sources for comparative studies of placentation I embryological collections. Placenta 29, 95-98 (2008)
doi:10.1016/j.placenta.2007.09.008
PMid:19689253

64. H. D. McIntyre, W. Zeck and A. Russell: Placental growth hormone, fetal growth and the IGF axis in normal and diabetic pregnancy. Curr Diabetes Rev 5, 185-189 (2009)
doi:10.2174/157339909788920947

65. V. Soloveva and D. I. H. Linzer: Differentiation of placental trophoblast giant cells requires downregulation of p53 and Rb. Placenta 25, 29-36 (2004)
doi:10.1016/S0143-4004(03)00215-7
PMid:12970191    PMCid:212738

66. T. Parisi, A. R. Beck, N. Rougier, T. McNeil, L. Lucian, Z. Werb and B. Amati: Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J 22, 4794-4803 (2003)
doi:10.1093/emboj/cdg482

67. F. Zhou, K. Tanaka, M. J. Soares and G. You: Characterization of an organic anion transport system in a placental cell line. Am J Physiol Endocrinol Metab 285, 1103-1109 (2003)
PMid:17536998

68. T. Jansson and T. L. Powell: Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 113, 1-13 (2007)
doi:10.1042/CS20060339
PMid:14977357

69. M. Piasek, M. Blanosa, K Kostial and J. W. Laskey: Low iron diet and parenteral cadmium exposure in pregnant rats: the effects on trace elements and fetal viability. BioMetals 17, 1-14 (2004)
doi:10.1023/A:1024426931676
PMid:12397409

70. M. Piasek, J. W. Laskey, K. Kostial and M. Blanusa: Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat in human placental tissue. Int Arch Occup Environ Health 75, S36-S44 (2002)
doi:10.1007/s00420-002-0351-3
PMid:19847775

71. S. Stasenko, E. M. Bradford, M. Piasek, M. C. Henson, V. M. Varnai, J. Jurasovic and V. Kusec: Metals in human placenta: focus on the effects of cadmium on steroid hormones and leptin. J Appl Toxicol 30, 242-253 (2010)
doi:10.1002/jat.1490
PMid:16325584

Key Words: Placenta, Ectoplacental Conus, Decidua, Rodent, Trophoblast, Review

Send correspondence to: Ljiljana Serman, Department of Biology, School of Medicine, University of Zagreb,Salata 3, 10 000 Zagreb, Croatia, Tel: 38514566952, Fax: 38514590199, E-mail:sermanl@mef.hr